Kinaxo Biotechnologies and Astrazeneca will collaborate using Kinaxo technology platform to support Astrazeneca oncology program

AstraZeneca plc

U.K. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Kinaxo Biotechnologies GmbH

Germany / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced